Perkins Capital Management’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-63,605
Closed -$5.1M 119
2016
Q4
$5.1M Sell
63,605
-3,068
-5% -$244K 5.59% 2
2016
Q3
$5.32M Hold
66,673
5.32% 3
2016
Q2
$5.2M Sell
66,673
-19,265
-22% -$1.37M 5.96% 2
2016
Q1
$4.73M Sell
85,938
-4,250
-5% -$232K 5.92% 1
2015
Q4
$5.57M Sell
90,188
-5,150
-5% -$325K 5.98% 1
2015
Q3
$6.01M Buy
95,338
+1,050
+1% +$74.9K 6.69% 1
2015
Q2
$6.89M Buy
94,288
+7,333
+8% +$530K 6.05% 2
2015
Q1
$5.69M Buy
86,955
+200
+0.2% +$13.3K 4.77% 1
2014
Q4
$5.64M Sell
86,755
-1,700
-2% -$109K 4.84% 1
2014
Q3
$5.32M Sell
88,455
-200
-0.2% -$13.1K 4.5% 1
2014
Q2
$6.14M Sell
88,655
-383
-0.4% -$24.8K 4.32% 2
2014
Q1
$5.82M Sell
89,038
-4,850
-5% -$316K 4.09% 2
2013
Q4
$5.82M Buy
93,888
+1,250
+1% +$72.4K 3.92% 2
2013
Q3
$4.97M Buy
92,638
+12,500
+16% +$644K 3.57% 2
2013
Q2
$3.66M Buy
+80,138
New +$3.47M 2.9% 2

Other funds holding STJ

Perkins Capital Management's STJ Position: Q1 2017 in Review

Perkins Capital Management sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 63,605 shares — an estimated $5.1M sold.

Perkins Capital Management first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $6.89M in Q2 2015. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Perkins Capital Management reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Perkins Capital Management sold 63,605 St Jude Medical shares in Q1 2017, an estimated $5.1M.
  • Perkins Capital Management first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Perkins Capital Management's St Jude Medical position peaked at $6.89M in Q2 2015.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Perkins Capital Management's 13F filing for Q1 2017, filed 19 Apr 2017.